Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Incidence and Mortality of Lung Cancer and Their Relationship to Development in Asia Publisher



Pakzad R1 ; Mohammadianhafshejani A2 ; Ghoncheh M3 ; Pakzad I4 ; Salehiniya H1, 5, 6
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Epidemiology and Biostatistics, School of Public Health, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Department of Epidemiology and Biostatistics, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran
  4. 4. Department of Microbiology, School of Medicine, Ilam University of Medical Sciences, Ilam, Iran
  5. 5. Minimally Invasive Surgery Research Center, Iran University of Medical Sciences, Tehran, Iran
  6. 6. Students' Scientific Research Center, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

Source: Translational Lung Cancer Research Published:2015


Abstract

Background: Lung cancer is the deadliest cancer worldwide and the most common cancer in Asia. It is necessary to get information on epidemiology and inequalities related to incidence and mortality of the cancer to use for planning and further research. This study aimed to investigate epidemiology and inequality of incidence and mortality from lung cancer in Asia. Methods: The study was conducted based on data from the world data of cancer and the World Bank [including the Human Development Index (HDI) and its components]. The incidence and mortality rates, and cancer distribution maps were drawn for Asian countries. To analyze data, correlation test between incidence and death rates, and HDI and its components at significant was used in the significant level of 0.05 using SPSS software. Results: A total of 1,033,881 incidence (71.13% were males and 28.87% were females. Sex ratio was 2.46) and 936,051 death (71.45% in men and 28.55% in women. The sex ratio was 2.50) recorded in Asian countries in 2012. Five countries with the highest standardized incidence and mortality rates of lung cancer were Democratic Republic of Korea, China, Armenia, Turkey, and Timor-Leste, respectively. Correlation between HDI and standardized incidence rate was 0.345 (P=0.019), in men 0.301 (P=0.042) and in women 0.3 (P=0.043); also between HDI and standardized mortality rate 0.289 (P=0.052), in men 0.265 (P=0.075) and in women 0.200 (P=0.182). Conclusions: The incidence of lung cancer has been increasing in Asia. It is high in men. Along with development, the incidence and mortality from lung cancer increases. It seems necessary to study reasons and factors of increasing the incidence and mortality of lung cancer in Asian countries. © Translational lung cancer research.
Related Docs
View other Related Docs
1. Incidence and Mortality of Bladder Cancer and Their Relationship With Development in Asia, Asian Pacific Journal of Cancer Prevention (2015)
2. The Incidence and Mortality of Esophageal Cancer and Their Relationship to Development in Asia, Annals of Translational Medicine (2016)
3. Prevalence of Lung Cancer in Isfahan Province, Iran, Journal of the Egyptian National Cancer Institute (2018)
4. The Incidence and Mortality of Prostate Cancer and Its Relationship With Development in Asia, Prostate International (2015)
5. Incidence and Mortality of Breast Cancer and Their Relationship to Development in Asia, Asian Pacific Journal of Cancer Prevention (2015)
6. Burden of Tracheal, Bronchus, and Lung Cancer in North Africa and Middle East Countries, 1990 to 2019: Results From the Gbd Study 2019, Frontiers in Oncology (2023)
7. Spatial Variation in Lung Cancer Mortality and Related Men–Women Disparities in Iran From 2011 to 2014, Cancer Management and Research (2020)
8. Temporal Patterns of Cancer Burden in Asia, 1990–2019: A Systematic Examination for the Global Burden of Disease 2019 Study, The Lancet Regional Health - Southeast Asia (2024)
Experts (# of related papers)
View all Related Experts
Kamal Heidari (3)
Zahra Tolou-Ghamari (2)
Other Related Docs
9. Cancer Epidemiology and Trends in Sistan and Baluchestan Province, Iran, Medical Journal of the Islamic Republic of Iran (2015)
10. Survival of Patients With Lung Cancer, Yazd, Iran, Asian Pacific Journal of Cancer Prevention (2012)
11. The Incidence and Mortality of Ovarian Cancer and Their Relationship With the Human Development Index in Asia, ecancermedicalscience (2016)
12. Regional Disparities in Cancer Survival in Iran: Insight From a National Surveillance of Cancer Survival in Iran (Irancansurv), Cancer Epidemiology (2023)
13. Application of Bayesian Multilevel Space-Time Models to Study Relative Risk of Esophageal Cancer in Iran 2005-2007 at a County Level, Asian Pacific Journal of Cancer Prevention (2015)
14. The Global Burden of Cancer Attributable to Risk Factors, 2010–19: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2022)
15. Geographic Distribution of Cancer Cases in Isfahan Province/2006–2010, International Journal of Preventive Medicine (2015)
16. The Epidemiology of Skin Cancer and Its Trend in Iran, International Journal of Preventive Medicine (2015)
17. National Surveillance of Cancer Survival in Iran (Irancansurv): Analysis of Data of 15 Cancer Sites From Nine Population-Based Cancer Registries, International Journal of Cancer (2022)
18. Modeling the Trend Changes of Liver Cancer Mortality in the 6 Who Regions, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology (2022)
19. Measuring Performance on the Healthcare Access and Quality Index for 195 Countries and Territories and Selected Subnational Locations: A Systematic Analysis From the Global Burden of Disease Study 2016, The Lancet (2018)
20. Cancer Incidence in Iran in 2014: Results of the Iranian National Population-Based Cancer Registry, Cancer Epidemiology (2019)
21. Death Portrait of Isfahan Province in Years 2007-2011, International Journal of Preventive Medicine (2016)
22. Cancer in Iran 2008 to 2025: Recent Incidence Trends and Short-Term Predictions of the Future Burden, International Journal of Cancer (2021)
23. The Global, Regional, and National Burden of Adult Lip, Oral, and Pharyngeal Cancer in 204 Countries and Territories: A Systematic Analysis for the Global Burden of Disease Study 2019, JAMA Oncology (2023)
24. Temporal Trends of Incidence of Colorectal Cancer in Isfahan, Iran, 2000-2011, International Journal of Preventive Medicine (2018)
25. Bivariate Spatiotemporal Disease Mapping of Cancer of the Breast and Cervix Uteri Among Iranian Women, Geospatial Health (2018)
26. Investigating the Incidence of Prostate Cancer in Iran 2005-2008 Using Bayesian Spatial Ecological Regression Models, Asian Pacific Journal of Cancer Prevention (2015)
27. Epidemiology and Trend of Cancers in the Province of Kerman: Southeast of Iran, Asian Pacific Journal of Cancer Prevention (2015)
28. Inflammatory Potential of Diet and Odds of Lung Cancer: A Case-Control Study, Nutrition and Cancer (2022)
29. The Burden of Prostate Cancer in North Africa and Middle East, 1990–2019: Findings From the Global Burden of Disease Study, Frontiers in Oncology (2022)
30. Incidence, Prevalence, and Mortality Rate of Gastrointestinal Cancer in Isfahan, Iran: Application of the Miamod Method, Asian Pacific Journal of Cancer Prevention (2016)
31. Lung Cancer Registry and Monitoring: Feasibility Study and Application (Fars Lung Cancer Registry Project), Journal of Research in Medical Sciences (2023)
32. Iranian Women Diagnosed With Breast Cancer a Decade Earlier Than British Women?, Journal of Kerman University of Medical Sciences (2022)
33. Epidemiological Features of Covid-19 in Iran, Journal of Research in Medical Sciences (2022)
34. Multiple Air Pollutant Exposure and Lung Cancer in Tehran, Iran, Scientific Reports (2021)
35. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 a Systematic Analysis for the Global Burden of Disease Study 2019, JAMA Oncology (2022)
36. Burden of Colorectal Cancer and Its Risk Factors in the North Africa and Middle East (Name) Region, 1990–2019: A Systematic Analysis of the Global Burden of Disease Study, BMC Public Health (2024)
37. The Trend in Histological Changes and the Incidence of Esophagus Cancer in Iran (2003–2008), International Journal of Preventive Medicine (2016)
38. Incidence and Risk Factors of Pancreatic Cancer During 15 Years Follow-Up in the Golestan Cohort Study in Iran, PLoS ONE (2024)
39. Frequency of Cancer Associated With Children and Adolescents, New Emirates Medical Journal (2024)
40. Epidemiology and Trend of Cancer in Isfahan 2005-2010, Journal of Research in Medical Sciences (2011)
41. Prevalence of Smoking in 15-64 Years Old Population of North of Iran: Meta-Analysis of the Results of Non-Communicable Diseases Risk Factors Surveillance System, Acta Medica Iranica (2013)
42. The Global Burden of Adolescent and Young Adult Cancer in 2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Oncology (2022)
43. The Most Common Cancers in Iranian Women, Iranian Journal of Public Health (2009)
44. International Epidemiology of Liver Cancer: Geographical Distribution, Secular Trends and Predicting the Future, Journal of Preventive Medicine and Hygiene (2020)
45. A Study of the Long-Term Trend of Epidemiological and Clinical Indices of Breast Cancer in Isfahan, Journal of Isfahan Medical School (2012)
46. Global Burden of Chronic Respiratory Diseases and Risk Factors, 1990–2019: An Update From the Global Burden of Disease Study 2019, eClinicalMedicine (2023)
47. Cancer Incidence and Prevalence in Isfahan: Application of Mortality Data to Estimates and Projects for the Period 2001-2015, International Journal of Preventive Medicine (2012)
48. Burden of Breast Cancer and Attributable Risk Factors in the North Africa and Middle East Region, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, Frontiers in Oncology (2023)
49. Global, Regional, and National Burden of Colorectal Cancer and Its Risk Factors, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Gastroenterology and Hepatology (2022)